These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27562553)

  • 1. A novel method to predict visual field progression more accurately, using intraocular pressure measurements in glaucoma patients.
    Japanese Archive of Multicentral Database in Glaucoma (JAMDIG) construction group
    Sci Rep; 2016 Aug; 6():31728. PubMed ID: 27562553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of data augmentation for visual field trend analyses in patients with glaucoma.
    Asaoka R; Murata H; Matsuura M; Fujino Y; Miki A; Tanito M; Mizoue S; Mori K; Suzuki K; Yamashita T; Kashiwagi K; Shoji N
    Br J Ophthalmol; 2020 Dec; 104(12):1697-1703. PubMed ID: 32111606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Visual Field Trend Analysis with OCT and Deeply Regularized Latent-Space Linear Regression.
    Xu L; Asaoka R; Murata H; Kiwaki T; Zheng Y; Matsuura M; Fujino Y; Tanito M; Mori K; Ikeda Y; Kanamoto T; Yamanishi K
    Ophthalmol Glaucoma; 2021; 4(1):78-88. PubMed ID: 32791238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Many Visual Fields Are Required to Precisely Predict Future Test Results in Glaucoma Patients When Using Different Trend Analyses?
    Taketani Y; Murata H; Fujino Y; Mayama C; Asaoka R
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4076-82. PubMed ID: 26114484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying "Lasso" Regression to Predict Future Visual Field Progression in Glaucoma Patients.
    Fujino Y; Murata H; Mayama C; Asaoka R
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2334-9. PubMed ID: 25698708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to measure visual field progression in glaucoma patients using variational bayes linear regression.
    Murata H; Araie M; Asaoka R
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8386-92. PubMed ID: 25414192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for visual field progression in treated glaucoma.
    De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
    Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma.
    Aoki S; Murata H; Fujino Y; Matsuura M; Miki A; Tanito M; Mizoue S; Mori K; Suzuki K; Yamashita T; Kashiwagi K; Hirasawa K; Shoji N; Asaoka R
    Br J Ophthalmol; 2017 Dec; 101(12):1658-1665. PubMed ID: 28450381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the Reliability of Glaucomatous Visual Field for the Accurate Assessment of Progression Using the Gaze-Tracking and Reliability Indices.
    Asaoka R; Fujino Y; Aoki S; Matsuura M; Murata H
    Ophthalmol Glaucoma; 2019; 2(2):111-119. PubMed ID: 32672604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The number of examinations required for the accurate prediction of the progression of the central 10-degree visual field test in glaucoma.
    Omoto T; Asaoka R; Akagi T; Oishi A; Miyata M; Murata H; Fujino Y; Hirasawa K; Inoue T; Tanito M; Shoji N
    Sci Rep; 2022 Nov; 12(1):18843. PubMed ID: 36344722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying "Lasso" Regression to Predict Future Glaucomatous Visual Field Progression in the Central 10 Degrees.
    Fujino Y; Murata H; Mayama C; Matsuo H; Asaoka R
    J Glaucoma; 2017 Feb; 26(2):113-118. PubMed ID: 27811574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database.
    Asano S; Murata H; Matsuura M; Fujino Y; Miki A; Tanito M; Mizoue S; Mori K; Suzuki K; Yamashita T; Kashiwagi K; Shoji N; Zangwill LM; Asaoka R
    Br J Ophthalmol; 2020 Apr; 104(4):569-574. PubMed ID: 31272952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustering visual field test points based on rates of progression to improve the prediction of future damage.
    Hirasawa K; Murata H; Hirasawa H; Mayama C; Asaoka R
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7681-5. PubMed ID: 25342611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of focal lamina cribrosa defect on glaucomatous visual field progression.
    Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
    Ophthalmology; 2014 Aug; 121(8):1524-30. PubMed ID: 24697910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of the Deep Learning method of variational autoencoder to reduce measurement noise in glaucomatous visual fields.
    Asaoka R; Murata H; Asano S; Matsuura M; Fujino Y; Miki A; Tanito M; Mizoue S; Mori K; Suzuki K; Yamashita T; Kashiwagi K; Shoji N
    Sci Rep; 2020 May; 10(1):7893. PubMed ID: 32398783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Axial Length and Progression of Visual Field Damage in Glaucoma.
    Yanagisawa M; Yamashita T; Matsuura M; Fujino Y; Murata H; Asaoka R
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):407-417. PubMed ID: 29351357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship between the Waveform Parameters from the Ocular Response Analyzer and the Progression of Glaucoma.
    Aoki S; Murata H; Matsuura M; Fujino Y; Nakakura S; Nakao Y; Kiuchi Y; Asaoka R
    Ophthalmol Glaucoma; 2018; 1(2):123-131. PubMed ID: 32672562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.